219325-45-8

Basic information

• Product Name: Benzoic acid (3S,6R,10S,13R)-3-(5-bromo-1H-indol-3-ylmethyl)-13-tert-butoxycarbonylamino-10-carbamoylmethyl-2,5,9,12-tetraoxo-1,4,8,11-tetraaza-cyclotetradec-6-yl ester
• CAS NO: 219325-45-8
• Molecular Weight: 756.61
• Mol File: 219325-45-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzoic acid (3S,6R,10S,13R)-3-(5-bromo-1H-indol-3-ylmethyl)-13-tert-butoxycarbonylamino-10-carbamoylmethyl-2,5,9,12-tetraoxo-1,4,8,11-tetraaza-cyclotetradec-6-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid (3S,6R,10S,13R)-3-(5-bromo-1H-indol-3-ylmethyl)-13-tert-butoxycarbonylamino-10-carbamoylmethyl-2,5,9,12-tetraoxo-1,4,8,11-tetraaza-cyclotetradec-6-yl ester(219325-45-8)
• EPA Substance Registry System: Benzoic acid (3S,6R,10S,13R)-3-(5-bromo-1H-indol-3-ylmethyl)-13-tert-butoxycarbonylamino-10-carbamoylmethyl-2,5,9,12-tetraoxo-1,4,8,11-tetraaza-cyclotetradec-6-yl ester(219325-45-8)

Safety Data

• Hazardous Substances Data: 219325-45-8(Hazardous Substances Data)

Upstream product

• 219325-44-7 benzoic acid 1-[2-(5-bromo-1H-indol-3-yl)-1-(9H-fluoren-9-ylmethoxycarbonyl)-ethylcarbamoyl]-2-{2-[2-tert-butoxycarbonylamino-3-(9H-fluoren-9-ylmethoxycarbonylamino)-propionylamino]-3-carbamoyl-propionylamino}-ethyl ester 
• 219325-43-6 benzoic acid 1-[2-(5-bromo-1H-indol-3-yl)-1-(9H-fluoren-9-ylmethoxycarbonyl)-ethylcarbamoyl]-2-(2-tert-butoxycarbonylamino-3-carbamoyl-propionylamino)-ethyl ester 
• 219325-42-5 Benzoic acid (R)-2-((S)-2-tert-butoxycarbonylamino-3-carbamoyl-propionylamino)-1-carboxy-ethyl ester 
• 131570-56-4 (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-((tertbutoxycarbonyl)amino)propanoic acid 
• 7536-55-2 N-t-butyloxycarbonyl-D-asparagine 
• 73259-81-1 (R)-2-tert-butoxycarbonyl-3-aminopropionic acid 

Relevant articles and documents

Studies related to the absolute configuration of cyclocinamide A: Total synthesis of 4(R),11(R)-cyclocinamide A

Coupling of the fluorenylmethyl ester 3 (R = Fm) of (S)-5- bromotryptophan with N(α)-BOC-(S)-asn-O-benzoyl-(R)-ise 9 gave rise to tripeptide 10. Cleavage of the BOC group in 10 followed by coupling with N(α)-BOC-N(β)-Fmoc-(R)-2,3-diaminopropanoic acid afforded tetrapeptide 11 which was transformed into cyclic peptide 12. Cleavage of the BOC in 12 followed by coupling with the glycine derived side chain 14 gave rise, after removal of the benzoyl group to 4(R),11(R)-cyclocinamide A(2) which was not identical to natural cyclocinamide A(1), suggesting that 1 possesses the 4(S),7(S),11(S),14(S) configuration.